New Target for Uveitis Therapy - Takeaways - MDSpire

New Target for Uveitis Therapy

  • May 21, 2026

Share

  • 1

    Uveitis is a major cause of vision loss, contributing to 15% of blindness in developed countries.

  • 2

    Current treatments like corticosteroids have limitations, especially in refractory uveitis cases.

  • 3

    The cGAS–STING pathway is identified as a potential new target for uveitis therapy.

  • 4

    Research using a mouse model showed that cGAS activation leads to increased ocular inflammation.

  • 5

    Targeting cGAS could provide a novel treatment strategy for patients unresponsive to existing therapies.

Original Source(s)

New Target for Uveitis Therapy

  • May 21, 2026

Related Content

Dropless Cataract Surgery: What is the fuss about?

As cataract surgery continues to evolve, the focus is shifting beyond the operating theatre to the weakest part of the patient pathway – postoperative drops

Ocular Surface Optimization: The Best First Step in Modern Cataract Surgery

Why a healthy preoperative ocular surface is no longer optional

Rethinking Uveal Melanoma Surveillance

Retrospective study questions whether uveal melanoma liver surveillance period should always be extended after five years

  • May 20, 2026

  • 3 min